SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (5607)9/15/1998 6:19:00 PM
From: Hong-Lee Yu  Read Replies (1) of 9719
 
Vector1,

Avonex sales for this quarter will be at least 102M, up from 87M in Q2. Analysts are raising the estimates and price target. I believe current avg. estimate for 1999 $2.33 are too low. they should be able to deliver at least 2.50.

As for price target, as long as drug Cos are considered safe heavens, BGEN should trade between 30 and 40 times 1999 earnings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News